We are live on ! Find out more
PAVM icon

PAVmed

65 hedge funds and large institutions have $19.2M invested in PAVmed in 2020 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 21 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

633% more capital inflows, than outflows

Capital inflows: $4.46M | Capital outflows: $609K

91% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 11

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

8% more funds holding

Funds holding: 60 → 65 (+5)

0.12% more ownership

Funds ownership: 13.8% → 13.93% (+0.12%)

Holders
65
Holders Change
+5
Holders Change %
+8.33%
% of All Funds
1.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
21
Reduced
11
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

PAVM Hedge Fund Activity: Q4 2020 in Review

65 of the 5,680 institutional investors tracked by Wall St. Rank reported a position in PAVmed (PAVM) for Q4 2020, worth a combined $19.2M — up 52% from $12.6M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new PAVM positions and 9 closed out — a net gain of 5 holders — while 21 added to existing stakes and 11 trimmed.

The largest buyer was Vanguard Group, adding an estimated $1.22M. The largest seller was Bank of America, cutting an estimated $164K.

  • 65 institutional investors held PAVmed (PAVM) as of Q4 2020, up from 60 in Q3 2020.
  • Funds reported $19.2M of PAVmed stock for Q4 2020, up 52% quarter-over-quarter.
  • 14 funds opened new PAVmed positions in Q4 2020 and 9 closed out, a net change of +5 holders.
  • The largest PAVmed buyer in Q4 2020 was Vanguard Group, an estimated $1.22M added.
  • The largest PAVmed seller in Q4 2020 was Bank of America, an estimated $164K sold.

Based on aggregated 13F filings for Q4 2020.